VANCOUVER, BRITISH COLUMBIA--(Marketwire - Feb. 1, 2012) - Eternity Healthcare Inc. (OTCBB:ETAH) (the "Company"), a medical device company, is pleased to announce today a major development in medical technologies. The Company introduces a new device for the injection of medicine into the body that does not require a needle. The technology has proven to be effective in administering greater than 95% of the medicine into the skin without the use of a needle. The technology is extremely fast and pain-free. This technology is believed to be ideal for diabetes patients for the injection of insulin, for other medicine in people with needle phobia, and children who are scared of needles. Other uses include drug injection in needle-exchange programs and vaccination. No needle is used, therefore there is no chance of contamination or cross infection phobia.

About Eternity Healthcare

Eternity Healthcare is a publically listed company in the United States under the stock symbol of "ETAH". The Company is the leader in medical technologies with state of the art medical devices, including diagnostic kits, digital cholesterol readers, injection free needles and more. For further information visit the Company's website: [ www.eternityhealthcare.com ].

Notice Regarding Forward Looking Statements

This press release includes forward-looking statements that involve a number of risks and uncertainties, including the success of the products in commercializing and developing. Further, the risks involve the ability of the Company to raise capital to fund its operations and the capital requirements for the development and marketing of its products. Investors are encouraged to review the risk factors listed or described from time to time in the Company's filings (10K) with the Securities and Exchange Commission.